2024.01.31.Guideline-for-Registration-of-Antiseptics-and-Disinfectants
2024.01.31.Guideline-for-Registration-of-Antiseptics-and-Disinfectants
","url":"http:\/\/www.efda.gov.et\/"}},"mobileHeader":{"firstSwitchPoint":990,"secondSwitchPoint":778,"firstSwitchPointHeight":80,"secondSwitchPointHeight":60},"stickyMobileHeaderFirstSwitch":{"logo":{"html":""}},"stickyMobileHeaderSecondSwitch":{"logo":{"html":""}},"content":{"textColor":"#8c95a2","headerColor":"#133d58"},"boxedWidth":"1340px","stripes":{"stripe1":{"textColor":"#dbdbdb","headerColor":"#ff9f1a"},"stripe2":{"textColor":"#333333","headerColor":"#203961"},"stripe3":{"textColor":"#000000","headerColor":"#203961"}}},"VCMobileScreenWidth":"778"};
var dtShare = {"shareButtonText":{"facebook":"Share on Facebook","twitter":"Tweet","pinterest":"Pin it","linkedin":"Share on Linkedin","whatsapp":"Share on Whatsapp","google":"Share on Google Plus"},"overlayOpacity":"85"}; /* ]]> */
2024.01.31.Guideline-for-Registration-of-Antiseptics-and-Disinfectants
2024.01.31.Guideline-for-Registration-of-oral-care-skin-care-products-with-therapeutic-claim
2024.02.27 Guidance-on-waiver-of-in-vivo-bioequivalence-requirements
2024.01.13 Guideline for describing the role and responsibilities of MA
2024.01.30 Guidelines for Registration of Biotherapeutic Proteint Products
2024.01.29 Guideline-for-Registration-of-Vaccine
2024.01.30 Guidelines on evaluation of similar biotherapeutics
Guidance on waiver of in vivo bioequivalence requirements